Medication info
Termina Tablet (Terbinafine Hydrochloride)

Termina Tablet (Terbinafine Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201701292 · Approved 2017.03.15

Summary

Main use
Treatment of onychomycosis and skin fungal infections (such as tinea pedis and tinea corporis)
Who uses it
Adults · Children
Adult dosage
Administer 125 mg of terbinafine per dose twice daily or 250 mg once daily. The treatment duration according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. For infection of the fingernails or relatively small toenails, or in younger patients, the treatment duration may be shortened to 3 months or less. Three months of treatment is usually sufficient for toenail infections, although some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. For patients with creatinine clearance below 50 mL per minute, reduce the daily dose by 1/2.
Children's dosage
Administer to children 2 years of age and older. Use is not recommended in children younger than 2 years because there is no experience with administration in this age group. Tinea capitis: 4 weeks 1) Body weight below 20 kg (younger than 5 years): Administer 62.5 mg per dose once daily. Because experience with administration is limited, the decision to administer should take into account the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of onychomycosis and skin fungal infections (such as tinea pedis and tinea corporis)

  • Dermatophyte infections
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used in adults for the treatment of dermatophyte infections such as tinea pedis, tinea corporis, and tinea cruris, as well as onychomycosis. It is also used for the treatment of tinea capitis in children. In summary, it helps improve various fungal infections occurring in the skin and nails.

Dosage and Administration

Adult dosage

Administer 125 mg of terbinafine per dose twice daily or 250 mg once daily. The treatment duration according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. For infection of the fingernails or relatively small toenails, or in younger patients, the treatment duration may be shortened to 3 months or less. Three months of treatment is usually sufficient for toenail infections, although some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. For patients with creatinine clearance below 50 mL per minute, reduce the daily dose by 1/2.

Children's dosage

Administer to children 2 years of age and older. Use is not recommended in children younger than 2 years because there is no experience with administration in this age group. Tinea capitis: 4 weeks 1) Body weight below 20 kg (younger than 5 years): Administer 62.5 mg per dose once daily. Because experience with administration is limited, the decision to administer should take into account the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

It is best to avoid using this medication in patients with chronic liver disease or active liver disease. Before taking this medication, it is essential to verify whether there is a history of liver disease. Since liver function could be affected, it is important to have regular liver function tests before and during the use of this medication. If liver function test results elevate, the use of this medication must be stopped immediately. If symptoms such as unexplained nausea, decreased appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice, dark urine, or diarrhea occur during treatment, notify a doctor immediately. This medication can rarely result in severe liver damage or liver failure, and in such cases, it must be discontinued immediately. Patients with allergic reactions to this medication or its ingredients, those with blood disorders or severe renal failure, children under 2 years of age, and nursing mothers should not take this medication. Additionally, patients with genetic metabolic disorders such as lactose intolerance should also not use this medication. Patients with decreased kidney function, elderly individuals over 65 years of age, and children under 20 kg should use this medication with caution. Severe skin reactions can rarely occur while taking this medication, so if skin rashes or unusual symptoms arise, discontinue use immediately. Caution is needed while driving or operating machinery as dizziness and other symptoms may occur. This medication can interact with other drugs, so it is important to inform your doctor or pharmacist if you are taking other medications. Women who are pregnant or may become pregnant should consult their doctor thoroughly if they need to take this medication. It is safe for nursing mothers to stop breastfeeding while on this medication. Overdose can result in headaches, nausea, upper abdominal pain, or dizziness; seek medical attention immediately if these symptoms occur. This medication must be stored out of reach of children and kept at room temperature, avoiding direct sunlight.

Side effects

Liver dysfunction, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, decreased appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriatic rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, nausea, mild abdominal pain, diarrhea, discomfort in the stomach, thirst, vomiting, glossitis, depression, anxiety, headache, taste disorder, dizziness, drowsiness, sensory disturbances, sensory loss, decreased attention, insomnia, elevated BUN, polyuria, visual impairment, tinnitus, anaphylactic reactions, angioedema, systemic lupus erythematosus, elevated blood total cholesterol, increased triglyceride levels, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reactions, serum sickness-like reactions, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is also recommended to keep it at room temperature between 1°C and 30°C. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.